Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
Leading National TMS provider—more locations, more doctors, more experience, more success!
Neuropsychological Testing
Where appropriate, patients will be asked to undergo neuropsychological testing prior to treatment. Assessments of this nature include but are not limited to:
- Intelligence Tests: WAIS; WISC; SB; TONI
- Achievement Tests: WJ-III; WIAT; WRAT
- Attention Tests: CCPT; WCST; Vanderbilt; NEPSY
- Language Tests: GORT; Boston Naming; HRB-Aphasia
- Memory and Learning Tests: WMS; WRAML; CVLT; RAVLT; ROCF; NEPSY
- Motor Control Tests: Grooved Pegoard; Finger Tapping; Grip Strength; Lateral Dominance
- Visual Spatial Tests: ROCFT; Bender-Gestalt; HVOT
- Autism Tests: ADOS; ASDS; ADL; GARS
- Executive Functioning Tests: WCST; BRIEF; EFSD; D-KEFS; HRB
- Behavioral Tests: BASC; Achenbach; Vanderbilt
Insurance coverage is widely available
Insurance Coverage Information
Patient Self Assessment & Tools
TMS Information for Practitioners
APA Guidelines
TMS Success Stories
NEWS / RESEARCH
